North Carolina’s global importance in agricultural biotechnology was highlighted again today as Syngenta Biotechnology founder Mary-Dell Chilton, Ph.D., became a 2013 World Food Prize Laureate.
News & Events
-
- Eboo Pharmaceuticals, a 2-year-old Durham biotechnology company has parlayed North Carolina Biotechnology Center support into a grant of up to $1.5 million from the high-profile Michael J. Fox Foundation for Parkinson’s Research.
- Weekly Grant Funding Opportunities
- The Sequenom Center for Molecular Medicine has opened its Morrisville laboratory for processing of the company’s MaterniT21 PLUS non-invasive prenatal blood test to detect Down syndrome from a woman’s blood sample as early as 10 weeks of pregnancy.
- Cook Medical, an Indiana medical device company with a major facility in Winston-Salem, has received marketing approval from the U.S. Food and Drug Administration for another enhancement in its line of gastrointestinal stents.
- The buzz about North Carolina’s agricultural biotechnology leadership got louder today when Bayer CropScience broke ground on its North American Bee Care Center in Research Triangle Park.
- Weekly Grant Funding Opportunities
- Anna Blade, who was working as a post-doc fellow at UNC Charlotte, used the NCBiotech Jobs Board to land a job as a laboratory consultant at WorldWide Medical Products.
-
- Durham’s Square 1 Bank has announced that it’s providing a term loan and revolving credit line to help drive the growth of Advanced Liquid Logic, one of NCBitoech’s high-flying bioscience success stories.
- Weekly Grant Funding Opportunities
- It's an acre under glass. It's India. Or Brazil. Or Nebraska. It's high-tech irrigation and feeding, environmentally friendly construction, and more light than you can imagine.
- By Jeremy Summers, NCBiotech Writer Life-science companies, start-ups, event sponsors, researchers and educators received $2.59 million in loans and grants from the North Carolina Biotechnology Center during the past fiscal quarter.
- Cempra, a Chapel Hill-based clinical-stage pharmaceutical company, has signed a license and development agreement for its antibiotic treatment for pneumonia with Japan-based Toyama Chemical.
- Chapel Hill biotech firm Heat Biologics filed for a $20 million IPO last week, as the company continues to secure funding for ongoing clinical trials of its unique platform for treating cancer and infectious diseases.
- Medicago has successfully produced a Virus-Like Particle vaccine candidate for the H7N9 virus, responsible for the recent avian flu outbreak in China.
- Weekly Grant Funding Opportunities
- David H. Murdock announced today a gift of $50 million to support the ongoing operational expenses of the David H. Murdock Research Institute and the North Carolina Research Campus.
- Dale Carroll, former deputy secretary and chief operating officer for the North Carolina Department of Commerce, has joined the North Carolina Biotechnology Center as executive director of the Western Office in Asheville.
- Liquidia Technologies is applying its novel nanotechnology-based development platform to products that will treat unmet needs in ophthalmology through the formation of a new company.
Pages
